Rapalogix Health, Inc.

Form D Filings

Location
New York, NY
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0002008372
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
6/4/2025 Equity $1,079,616 $9,079,616 $13,500,000 $4,420,384 12/22/2023 6/4/2025 D/A 000200837225000002
1/16/2024 Equity $8,000,000 $8,000,000 $8,000,000 $0 12/22/2023 1/11/2024 D 000200837224000001